Published in
American Association for the Advancement of Science, Science Translational Medicine, 592(13), 2021
DOI: 10.1126/scitranslmed.abg7673
Links
Tools
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
Journal article published in 2021 by
Gabriele Pollara 
,
Carolin T. Turner ,
Joshua Rosenheim ,
Aneesh Chandran ,
Lucy C. K. Bell ,
Ayesha Khan ,
Amit Patel ,
Luis Felipe Peralta ,
Anna Folino ,
Ayse Akarca ,
Cristina Venturini ,
Tina Baker,
Simone Ecker ,
Fabio L. M. Ricciardolo ,
Teresa Marafioti
and other authors.
,
Carolin T. Turner ,
Joshua Rosenheim ,
Aneesh Chandran ,
Lucy C. K. Bell ,
Ayesha Khan ,
Amit Patel ,
Luis Felipe Peralta ,
Anna Folino ,
Ayse Akarca ,
Cristina Venturini ,
Tina Baker,
Simone Ecker ,
Fabio L. M. Ricciardolo ,
Teresa Marafioti
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
In vivo IL-17A activity is elevated in active tuberculosis and may be a therapeutic target to attenuate disease-associated immunopathology.